Clinical trial Recruiting at 1 site Observational Ages 1 Day to 18

Investigating how anti-infectives work in critically ill children

Official title: Population Pharmacokinetics and Rationalization of Anti-infectives Administration in Critically Ill Children

Run by Assistance Publique - Hôpitaux de Paris · NCT02539407 · Data updated 2026-11-12

This study is trying to see how different anti-infective medications work in critically ill children to help figure out the best doses for them.

More Intensive Care Unit trials

Quick facts

Study typeObservational
Ages1 Day to 18 Years
SexAll
Enrollment3000 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedSeptember 11, 2015
Main results expectedOctober 2028
Study endsDecember 2028
Registry record updatedNovember 20, 2025
Trial IDNCT02539407 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are critically ill children who require the administration of specific anti-infectives during their hospitalization.

Probably not a fit

Patients whose parents refuse data recovery will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to understand the pharmacokinetics and pharmacodynamics of various anti-infectives in critically ill pediatric patients. By analyzing blood samples from children receiving these medications, the study seeks to identify how individual factors affect drug concentrations and clinical outcomes. The goal is to address the significant variability in drug response among critically ill children and to propose more personalized dosing regimens. The study will take place across six pediatric services in public hospitals in Paris, France.

Why it matters

Potential benefit: If successful, this study could lead to improved dosing strategies for anti-infectives in critically ill children, potentially enhancing their clinical outcomes.

How similar studies have gone: While studies have shown variability in drug response in critically ill adults, this specific approach in critically ill children is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Minor patient requiring the administration of an anti-infective belonging to the following classes : β-lactam antibiotics; aminoglycosides, glycopeptides; fluoroquinolones; other antibiotics (daptomycin, rifampin, trimethoprim, sulfamethoxazole, clarithromycin); fungal; antivirals, during its follow-up or hospitalization

Exclusion Criteria:

* Patient and parents having notified to the doctor that they refuse data recovery.

Where it's running

  • Hospital Necker - Enfants Malades (Public Hospitals of Paris)
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.